Home > Authorities > Institutes > Record #170070 |
W630
Radiopharmazeutika und Präklinische StudienID | I:(DE-He78)W630-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
European journal of nuclear medicine and molecular imaging nn, nn (2025) [10.1007/s00259-025-07427-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.
Pharmaceuticals 18(6), 906 (2025) [10.3390/ph18060906]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Structure–Activity Relationships and Biological Insights into PSMA-617 and Its Derivatives with Modified Lipophilic Linker Regions
ACS omega 10(7), 7077-7090 (2025) [10.1021/acsomega.4c10142]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Concept validation of separations for thorium-based radionuclide generator systems for medical application
Frontiers in Nuclear Engineering 3, - (2024) [DOI:10.5445/IR/1000176410]
BibTeX |
EndNote:
XML,
Text |
RIS
Preprint
Semantic Representation of Preclinical Data in Radiation Oncology.
Journal of biomedical semantics (2024) [10.21203/rs.3.rs-5373454/v1] special issue: "ICBO Thematic Series Collection"
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Letter)
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
ACS medicinal chemistry letters 15(11), 1970–1978 (2024) [10.1021/acsmedchemlett.4c00324]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy.
Pharmaceuticals 17(8), 1031 (2024) [10.3390/ph17081031]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
Pharmaceuticals 17(4), 513 (2024) [10.3390/ph17040513]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Synthesis of tritium-labeled Lu-PSMA-617: Alternative tool for biological evaluation of radiometal-based pharmaceuticals.
Applied radiation and isotopes 197, 110819 (2023) [10.1016/j.apradiso.2023.110819]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.
Pharmaceuticals 15(10), 1292 (2022) [10.3390/ph15101292]
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |